Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-08-12

Clinical Trial Update: Study on the Efficacy and Safety of a Novel Tripterygium Wilfordii Preparation in Reducing Proteinuria in Patients With Diabetic Nephropathy [NA]

View source ↗

Summary

A completed clinical trial evaluated the efficacy and safety of a novel Tripterygium wilfordii preparation for reducing proteinuria in diabetic nephropathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tripterygium wilfordii preparation (Tripterygium wilfordii extract)

Snippet

Sponsor: First Affiliated Hospital Xi'an Jiaotong University | Conditions: Diabetic Nephropathy | NA | Status: COMPLETED